Cargando…
Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients
The pioneer transcription factor (TF) PU.1 controls hematopoietic cell fate by decompacting stem cell heterochromatin and allowing nonpioneer TFs to enter otherwise inaccessible genomic sites. PU.1 deficiency fatally arrests lymphopoiesis and myelopoiesis in mice, but human congenital PU.1 disorders...
Ejemplares similares
-
Screening for severe combined immunodeficiency in neonates
por: Kelly, Brian T, et al.
Publicado: (2013) -
A Practical Approach to Newborn Screening for Severe Combined Immunodeficiency Using the T Cell Receptor Excision Circle Assay
por: Thakar, Monica S., et al.
Publicado: (2017) -
Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome
por: Yang, Chao, et al.
Publicado: (2019) -
Astrovirus Encephalitis in Boy with X-linked Agammaglobulinemia
por: Quan, Phenix-Lan, et al.
Publicado: (2010) -
X-linked agammaglobulinemia (XLA): Phenotype, diagnosis, and therapeutic challenges around the world
por: El-Sayed, Zeinab A., et al.
Publicado: (2019)